Business Context and Reporting Period
This Form 8-K is a current report filed by Intrexon Corporation on November 30, 2017, covering events that occurred on November 27, 2017. The filing details significant executive leadership changes at Intrexon Corporation and its wholly-owned subsidiary, Precigen, Inc.
Key Financial Metrics
The filing text does not provide specific financial data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The report focuses exclusively on personnel changes and regulatory disclosures.
Material Changes
- Chief Operating Officer: Lt. Gen. (Ret.) Thomas Bostick, Ph.D., was promoted to Chief Operating Officer, replacing Andrew Last, Ph.D., who is departing the company.
- Chief Business Officer: Nir Nimrodi was promoted to the newly created position of Chief Business Officer.
- Precigen Leadership: Helen Sabzevari, PhD, was promoted to President of Precigen, Inc.
- Severance Arrangement: Departing executive Dr. Last is entitled to a severance payment equivalent to sixteen weeks of base pay and up to four months of continued health benefits, subject to a general release.
Outlook, Risks, and Management Commentary
Management commentary is limited to the announcement of the promotions and the background of the incoming executives. Lt. Gen. Bostick brings 38 years of U.S. Army service, including command of the U.S. Army Corps of Engineers. The filing notes that the full text of Dr. Last's severance agreement will be filed as an exhibit to the Form 10-K for the year ending December 31, 2017. No specific financial guidance, risks, or contingencies are disclosed in this document.
Investor Verification Checklist
- Verify the full terms of the severance agreement for Andrew Last, Ph.D., in the upcoming Form 10-K filing.
- Review the press release (Exhibit 99.1) for additional strategic context regarding the leadership changes.
- Confirm the operational impact of the new leadership structure on Intrexon's Environment Sector and Precigen, Inc.